We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Company Failed to Investigate Device Complaints
FDA Says Company Failed to Investigate Device Complaints
February 1, 2007
HemoSense's medical devices are adulterated due to cGMP violations regarding its complaint-handling and investigating system, an FDA warning letter said.